JP Morgan Chase’s Daxor DXR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61 Buy
6
+5
+500% +$51 ﹤0.01% 7574
2026
Q1
$10 Sell
1
-4
-80% -$49 ﹤0.01% 7431
2025
Q4
$74 Buy
5
+1
+25% +$13 ﹤0.01% 7234
2025
Q3
$54 Hold
4
﹤0.01% 7215
2025
Q2
$39 Hold
4
﹤0.01% 6912
2025
Q1
$33 Sell
4
-1
-20% -$8 ﹤0.01% 7045
2024
Q4
$38 Hold
5
﹤0.01% 7177
2024
Q3
$43 Hold
5
﹤0.01% 7142
2024
Q2
$48 Hold
5
﹤0.01% 7035
2024
Q1
$42 Buy
5
+1
+25% +$9 ﹤0.01% 7071
2023
Q4
$38 Buy
4
+2
+100% +$17 ﹤0.01% 7242
2023
Q3
$18 Buy
+2
New +$19 ﹤0.01% 7191

Other funds holding DXR

JP Morgan Chase's DXR Position: Q2 2026 in Review

JP Morgan Chase increased its Daxor (DXR) stake by 500% in Q2 2026, buying an estimated $51 and bringing the position to 6 shares worth $61. The position accounts for ﹤0.01% of the portfolio, ranked #7574.

JP Morgan Chase first reported a position in DXR in Q3 2023 and has held it in 12 quarters since. The position peaked at $74 in Q4 2025. 6 funds tracked by Wall St. Rank hold DXR as of Q2 2026.

  • JP Morgan Chase held 6 shares of Daxor worth $61 as of Q2 2026.
  • JP Morgan Chase bought 5 Daxor shares in Q2 2026, an estimated $51.
  • Daxor made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7574 holding.
  • JP Morgan Chase first reported a position in Daxor in Q3 2023 and has held it in 12 quarters since.
  • JP Morgan Chase's Daxor position peaked at $74 in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Daxor as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.